Back

prof. dr. R.E.G. Schutgens

prof. dr. R.E.G. Schutgens

Full Professor
prof. dr. R.E.G. Schutgens
  • Hematology/Van Creveldclinic

Biography

Biography

Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.

Side Activities

Advisory Board Member Horizonscan geneesmiddelen ZonMW

Scientific Editor HemaSphere (the EHA journal)

Co-owner general practice 'Huisartsenpraktijk Voordorp'

Research Output (261)

High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands:retrospective data from the RBiN study

Maas Dominique P.M.S.M., Saes Joline L., Blijlevens Nicole M.A., Cnossen M. H., den Exter P. L., van der Heijden Olivier W.H., Kruis I. C., Meijer Karina, Peters Marjolein, Schutgens Roger E.G., van Heerde W. L., Nieuwenhuizen L., Schols S. E.M., Maas D. P.M.S.M., Saes Joline L., Meijer K., Cnossen M. H., Schutgens Roger E.G., Peters M., Nieuwenhuizen L., den Exter P. L., Kruis I. C., van Heerde W. L., Schols S. E.M., Oct 2023, In: Journal of Thrombosis and Haemostasis. 21 , p. 2726-2734 9 p.

DosEmi study protocol:a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A

Donners Anouk, van der Zwet Konrad, Egberts Antoine C G, Fijnvandraat Karin, Mathôt Ron, Kruis Ilmar, Cnossen Marjon H, Schutgens Roger, Urbanus Rolf T, Fischer Kathelijn 26 Jun 2023, In: BMJ Open. 13

Insights in the Prothrombotic Changes after Implantation of a Left Ventricular Assist Device in Patients with End-Stage Heart Failure:A Longitudinal Observational Study

Liesdek Omayra C.D., Urbanus Rolf T., De Maat Steven, De Heer Linda M., Ramjankhan Faiz Z., Sebastian Silvie A.E., Huisman Albert, De Jonge Nicolaas, Vink Aryan, Fischer Kathelijn, Maas Coen, Suyker Willem J.L., Schutgens Roger E.G. 1 May 2023, In: ASAIO journal. 69 , p. 438-444 7 p.

Structural changes after ankle joint distraction in haemophilic arthropathy:an explorative study investigating biochemical markers and 3D joint space width

van Bergen Eline D P, Mastbergen Simon C, Lafeber Floris P J G, Bay-Jensen Anne-Christine, Madsen Sofie F, Port Helena, Foppen Wouter, Schutgens Roger E G, Jansen Mylène P, van Vulpen Lize F D May 2023, In: Haemophilia. 29 , p. 874-882 9 p.

Evaluation of the procoagulant state in chronic immune thrombocytopenia before and after eltrombopag treatment—a prospective cohort study

van Dijk Wobke E.M., Poolen Geke C., Huisman Albert, Koene Harry R., Fijnheer Rob, Thielen Noortje, van Bladel Esther R., van Galen Karin P.M., Schutgens Roger E.G., Urbanus Rolf T. Apr 2023, In: Journal of Thrombosis and Haemostasis. 21 , p. 1020-1031 12 p.

No immunological changes after factor VIII product switch:An in depth analysis in haemophilia A patients

Schep Sarah J, Fischer Kathelijn, Boes Marianne, Schutgens Roger E G 2023, In: Haemophilia. 29 , p. 1039-1048 10 p.

Magnetic resonance imaging evidence for subclinical joint bleeding in a Dutch population of people with severe hemophilia on prophylaxis

van Leeuwen Flora H P, van Bergen Eline D P, Timmer Merel A, van Vulpen Lize F D, Schutgens Roger E G, de Jong Pim A, Fischer Kathelijn, Foppen Wouter 2023, In: Journal of Thrombosis and Haemostasis. 21 , p. 1156-1163 8 p.

Proof of concept and feasibility of a blended physiotherapy intervention for persons with haemophilic arthropathy

Timmer Merel A, Kuijlaars Isolde A R, Kloek Corelien, de Kleijn Piet, Schutgens Roger E G, Veenhof Cindy, Pisters Martijn F 17 Nov 2022, In: Haemophilia. 29 , p. 290-307 18 p.

Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling

Janssen Alexander, Hoogendoorn Mark, Cnossen Marjon H., Mathôt Ron A.A., Cnossen M. H., Reitsma S. H., Leebeek F. W.G., Mathôt R. A.A., Fijnvandraat K., Coppens M., Meijer K., Schols S. E.M., Eikenboom H. C.J., Schutgens R. E.G., Beckers E. A.M., Ypma P., Kruip M. J.H.A., Polinder S., Tamminga R. Y.J., Brons P., Fischer K., van Galen K. P.M., Heubel-Moenen F. C.J.I., Nieuwenhuizen L., Driessens M. H.E., van Vliet I., Lock J., Hazendonk H. C.A.M., van Moort I., Heijdra J. M., Goedhart M. H.J., Al Arashi W., Preijers T., de Jager N. C.B., Bukkems L. H., Cloesmeijer M. E., Janssen A., Collins P. W., Liesner R., Chowdary P., Millar C. M., Hart D., Keeling D., Aug 2022, In: CPT: Pharmacometrics and Systems Pharmacology. 11 , p. 1100-1110 11 p.

Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units:A retrospective cohort study

Noordermeer Tessa, Schutgens Roger E G, Visser Chantal, Rademaker Emma, de Maat Moniek P M, Jansen A J Gerard, Limper Maarten, Cremer Olaf L, Kruip Marieke J H A, Endeman Henrik, Maas Coen, de Laat Bas, Urbanus Rolf T, Aug 2022, In: Research and practice in thrombosis and haemostasis. 6

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet